Society for Immunotherapy of Cancer
@sitcancer
Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.
SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. sitcancer.org/advocacy/indir…
Submit Late-breaking Abstracts – Clinical Only that highlight novel and practice-changing clinical studies for #SITC25. LBA submission deadline is Sept. 15. Additional oral presentation opportunities available! sitcancer.org/2025/abstracts… #immunotherapy
Society for Immunotherapy of Cancer - Congratulations to the 2025 SITC Forward Fund Fellowship Recipients @sitcancer oncodaily.com/blog/society-f… #SITC #Immunotherapy #ImmuneOnc #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
Congratulations to Dr. Anna Ralser of @GladstoneInst, recipient of the 2025 SITC-Merck Cancer Immunotherapy Clinical Fellowship, a 1-year, $100K SITC Fellowship! #fellowship #ForwardFund sitcancer.org/professional-d…
#SITC25 Science Preview: Join @HaanenJohn @NKI_nl, @DrKedarKirtane @MoffittNews, @JennGuerriero @BrighamSurgery, Parameswaran Hari, MD, Obsidian Therapeutics and @jasonlukemd @UPMCHillmanCC to explore cell therapies beyond CAR T cells. Learn more: ow.ly/FfmJ50WuJ5k
Join #SITC Winter School and learn the core principles of #tumor #immunology, #cancer #immunotherapy, biomarker technology, validation and clinical integration. Register at sitcancer.org/edu/winterscho… Register by Dec. 19 and save up to $250.
Check out the publication of a new manuscript titled, “Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee” on @jitcancer: jitc.bmj.com/content/13/6/e…
Upcoming Webinar on Aug. 21! Assessing the #Tumor #Microenvironment with Systems #Immunology will delve into how comp #science & single #cell spatial #technologies are revolutionizing the study of the #TME, focusing on tumor #immune interactions. Register: sitcancer.org/CompIO
Congratulations to Dr. Mohamad Ali Najia of @BostonChildrens recipient of the 2025 SITC-Genmab Cancer Immunotherapy in Hematologic Malignancies: DLBCL, FL, and CLL Translational Fellowship, a 1-year, $100K SITC Fellowship! #ForwardFund sitcancer.org/professional-d…
Register for our 40th Anniversary Annual Meeting and Pre-Conference Programs. #SITC25 consists of cutting-edge research presentations by experts in the field. Early registration ends Aug. 13 - Save up to $200 off regular rates. sitcancer.org/2025/home
Thank you to our partners and participants for making the WIC-APAC 2025 a success! This collaborative effort continues to build lasting partnerships and spark meaningful dialogue. Continue the conversation at SITC 2025! Don’t miss the 6th WIC Symposium: sitcancer.org/2025/schedule/…
Manage NSCLC in the perioperative, metastatic, & second-line setting with insights from leading experts! Join us Sept. 12 for a live virtual cancer #immunotherapy program, ACI: A Focus on Lung Cancers. Register: sitcancer.org/edu/aci/lung-c… @marinagarassino @HendriksLizza @ChaftJamie
Very well deserved!
Honored and grateful to receive funding from @sitcancer to support my postdoc research on the therapeutic potential of endogenous retroelements in blood cancers!
Please join us in congratulating the recipients of the 2025 SITC #ForwardFund Fellowships. Through dedicated funding, these fellowships help support the next generation of cancer immunotherapy professionals. Learn more about the recipients here: sitcancer.org/professional-d…
Designing a #cancer #immunotherapy clinical trial? #SITC SCION 2026 attendees will learn from leading experts and navigate unique considerations that accompany cancer immunotherapy trials. Feb. 16–18, 2026 in Boston, MA. Apply by Aug. 7: sitcancer.org/career-develop…
New #JITC article: Unveiling the mechanisms of CEBPD-orchestrated TAM polarization through RGS2/PAR2 pathway and its impact on ICB efficacy in clear cell renal cell carcinoma bit.ly/4eYJknP
Cant wait to host all our guests and friends to World ImmunoTherapy Council APAC that will be held at @mysgh. @SingHealthSG @sitcancer @parkerici AI system developed in Singapore could help predict liver cancer recurrence | The Straits Times share.google/vsc8aYAOlmG587…
Stay current with global #IO standards and discover cutting-edge science at #SITC25 in National Harbor, MD or virtually Nov. 5–9! Translate the latest breakthroughs to patient care with insights from international leaders. Early registration ends Aug. 13: sitcancer.org/2025/home
The 2026 SCION Workshop has award opportunities! Check out our Martin “Mac” Cheever Excellence In Clinical Trial Design Travel Award. Awardees receive reimbursement to support their travel to the 2026 SITC Annual Meeting. Learn more: sitcancer.org/career-develop…
Catch the latest cancer #immunotherapy research and updates with the July #JITC Digest! Get key takeaways on launching IO therapies with insights from the SITC Biotech Strategic Meeting at the NYSE. Access panel highlights and expert perspectives! ow.ly/lhu250WqB30
New #JITC letter: Correspondence on “METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5/CCL5 regulation” by Tong et al bit.ly/3GGr1Hc